Clinical and genomic responses to ultra-short course chemotherapy in spinal tuberculosis

Niu,Ningkui; Wang,Qian; Shi,Jiandang; Zhang,Xu; Geng,Guangqi; Zhou,Shufeng; Thach,Chia; Cheng,Feng; Wang,Zili

doi:10.3892/etm.2017.4170

May-2017 Volume 13 Issue 5

Full Size Image

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

An International Open Access Journal Devoted to General Medicine.

May-2017 Volume 13 Issue 5

Full Size Image

Article Open Access

Clinical and genomic responses to ultra-short course chemotherapy in spinal tuberculosis

Authors:
- Ningkui Niu
- Qian Wang
- Jiandang Shi
- Xu Zhang
- Guangqi Geng
- Shufeng Zhou
- Chia Thach
- Feng Cheng
- Zili Wang
View Affiliations / Copyright

Affiliations: Department of Spinal Surgery, General Hospital of Ningxia Medical University, Yinchuan, Ningxia 750004, P.R. China, Department of Pharmaceutical Sciences, College of Pharmacy, University of South Florida, Tampa, FL 33612, USA, Department of Beijing National Biochip Research Center Sub‑center in Ningxia, General Hospital of Ningxia Medical University, Yinchuan, Ningxia 750004, P.R. China

Copyright: © Niu et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
Pages: 1681-1688
|
Published online on: March 2, 2017

https://doi.org/10.3892/etm.2017.4170
Expand metrics +

Abstract

Traditional treatments for spinal tuberculosis (TB) involve chemotherapy and surgery. In the present study, it has been identified that chemotherapy lasting <6 months [ultra‑short course chemotherapy (UCCT)], rather than the 6‑18 months of the traditional regimen, is effective in sustaining TB clearance following complete surgical debridement. This current study aims to compare the changes in peripheral blood gene expression prior to and following UCCT, subsequent to complete debridement of spinal TB lesions. The study includes 5 patients without TB and 27 patients with spinal, divided into three groups: Group 1 (untreated group, n=8); group 2 (UCCT treatment group, n=9); and group 3 (UCCT treatment 1 year follow-up group, n=10). Gene changes were detected using DNA microarray analysis, confirmed through reverse transcription-quantitative polymerase chain reaction (RT‑qPCR) and the results were examined using the DAVID Knowledgebase to identify the pathways and functions of differentially expressed genes. TB lesions were active in group 1, while groups 2 and 3 showed no signs of active TB, as indicated by clinical manifestations and imaging. Comparison of the transcription profiles of the control and study groups showed that treatment of spinal TB resulted in upregulation of genes that are associated with immune response pathways; RT‑qPCR produced similar findings. In conclusion, these results indicate that UCCT is an effective treatment against TB following complete surgical debridement. Furthermore, DNA microarray analysis proved a useful tool to evaluate the effects of spinal TB treatment on the expression of genes associated with immune response pathways.

View Figures

View References

1	Onozaki I: National surveys of the prevalence of tuberculosis disease-overview, progress and lessons learnt. Kekkaku. 88:777–783. 2013.(In Japanese). PubMed/NCBI
2	Rasouli MR, Mirkoohi M, Vaccaro AR, Yarandi KK and Rahimi-Movaghar V: Spinal tuberculosis: Diagnosis and management. Asian Spine J. 6:294–308. 2012. View Article : Google Scholar : PubMed/NCBI
3	Karaeminogullari O, Aydinli U, Ozerdemoglu R and Ozturk C: Tuberculosis of the lumbar spine: Outcomes after combined treatment of two-drug therapy and surgery. Orthopedics. 30:55–59. 2007.PubMed/NCBI
4	Wang Z, Shi J, Geng G and Qiu H: Ultra-short-course chemotherapy for spinal tuberculosis: Five years of observation. Eur Spine J. 22:274–281. 2013. View Article : Google Scholar : PubMed/NCBI
5	Jin W and Wang Z: Clinical evaluation of the stability of single-segment short pedicle screw fixation for the reconstruction of lumbar and sacral tuberculosis lesions. Arch Orthop Trauma Surg. 132:1429–1435. 2012. View Article : Google Scholar : PubMed/NCBI
6	Wang Z, Ge Z, Jin W, Qiao Y, Ding H, Zhao H, Lin Z, Chen J and Yang W: Treatment of spinal tuberculosis with ultrashort-course chemotherapy in conjunction with partial excision of pathologic vertebrae. Spine J. 7:671–681. 2007. View Article : Google Scholar : PubMed/NCBI
7	Wang Z: Complete removal of the lesions of spinal tuberculosis and its related issues opinion. Chinese Journal of Spine and Spinal Cord. 18:568–570. 2008.
8	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(−Delta Delta C(T)) Method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
9	Ge Z, Wang Z and Wei M: Measurement of the concentration of three antituberculosis drugs in the focus of spinal tuberculosis. Eur Spine J. 17:1482–1487. 2008. View Article : Google Scholar : PubMed/NCBI
10	Eisen MB, Spellman PT, Brown PO and Botstein D: Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci USA. 95:14863–14868. 1998. View Article : Google Scholar : PubMed/NCBI
11	Dennis G Jr, Sherman BT, Hosack DA, Yang J, Gao W, Lane HC and Lempicki RA: DAVID: Database for Annotation, visualization, and Integrated Discovery. Genome Biol. 4:P32003. View Article : Google Scholar : PubMed/NCBI
12	Liu Y, Wang Y, Teng Z, Zhang X, Ding M, Zhang Z, Chen J and Xu Y: DNA microarray analysis in screening features of genes involved in spinal cord Injury. Med Sci Monit. 22:1571–1581. 2016. View Article : Google Scholar : PubMed/NCBI
13	Young DB, Perkins MD, Duncan K and Barry CE III: Confronting the scientific obstacles to global control of tuberculosis. J Clin Invest. 118:1255–1265. 2008. View Article : Google Scholar : PubMed/NCBI
14	Mistry R, Cliff JM, Clayton CL, Beyers N, Mohamed YS, Wilson PA, Dockrell HM, Wallace DM, van Helden PD, Duncan K and Lukey PT: Gene-expression patterns in whole blood identify subjects at risk for recurrent tuberculosis. J Infect Dis. 195:357–365. 2007. View Article : Google Scholar : PubMed/NCBI
15	Jacobsen M, Repsilber D, Gutschmidt A, Neher A, Feldmann K, Mollenkopf HJ, Ziegler A and Kaufmann SH: Candidate biomarkers for discrimination between infection and disease caused by Mycobacterium tuberculosis. J Mol Med (Berl). 85:613–621. 2007. View Article : Google Scholar : PubMed/NCBI
16	Ockenhouse CF, Bernstein WB, Wang Z and Vahey MT: Functional genomic relationships in HIV-1 disease revealed by gene-expression profiling of primary human peripheral blood mononuclear cells. J Infect Dis. 191:2064–2074. 2005. View Article : Google Scholar : PubMed/NCBI
17	Bleharski JR, Li H, Meinken C, Graeber TG, Ochoa MT, Yamamura M, Burdick A, Sarno EN, Wagner M, Röllinghoff M, et al: Use of genetic profiling in leprosy to discriminate clinical forms of the disease. Science. 301:1527–1530. 2003. View Article : Google Scholar : PubMed/NCBI
18	Cooper AM: Cell-mediated immune responses in tuberculosis. Annu Rev Immunol. 27:393–422. 2009. View Article : Google Scholar : PubMed/NCBI

Journals

International Journal of Molecular Medicine

International Journal of Oncology

Molecular Medicine Reports

Oncology Reports

Experimental and Therapeutic Medicine

Oncology Letters

Biomedical Reports

Molecular and Clinical Oncology

World Academy of Sciences Journal

International Journal of Functional Nutrition

International Journal of Epigenetics

Medicine International

Clinical and genomic responses to ultra-short course chemotherapy in spinal tuberculosis

This article is mentioned in:

Abstract

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

Figure 6

Figure 7

Figure 8

Related Articles